Cannabis, sport & fitness — the knowledge hub

Cannabis and sport: between recovery and performance impairment

The discussion about cannabis in sport regularly mixes three different questions: what does it do physiologically, what is permitted under anti-doping regulations, and what helps with recovery? Physiologically, the findings are sobering: THC does not improve athletic performance. It increases heart rate, alters the perception of effort, and impairs coordination and reaction time — for strength and endurance performance, this is not an advantage, but a disadvantage in most disciplines.

The recovery side is more interesting. The endocannabinoid system is involved in pain modulation, inflammation regulation, and sleep, and anandamide plays a role in the discussion surrounding the «runner's high». This is where the interest in CBD stems from: not as a performance enhancer, but for sleep quality, muscular discomfort, and recovery between physical exertion. The evidence for this exists, but is limited and methodologically heterogeneous — reliable effect sizes for athletic populations are largely lacking.

Honestly summarized: CBD is a plausible building block in recovery, not a substitute for sleep, nutrition, and load management. And THC is simply counterproductive in the context of training.

• THC: no performance-enhancing effect, coordination and reaction impaired
• CBD: not on the WADA Prohibited List since 2018
• THC remains prohibited in competition — urine threshold at 150 ng/mL carboxylic acid
• Full-spectrum CBD poses a real risk of contamination for competitive athletes

Anti-doping reality and the Swiss legal situation

CBD was removed from the WADA Prohibited List in 2018, all other cannabinoids including THC remain prohibited in competition. This sounds clear-cut, but in practice it is not: full-spectrum CBD products contain legal residual THC, and this is precisely what leads to positive doping tests. For licensed athletes, the principle of strict liability applies — anyone who consumes a contaminated product is still liable. Anyone subject to Antidoping Schweiz should therefore only use tested isolate products with a THC-free certificate of analysis.

Outside of competitive sports, the standard framework applies: under 1% total THC is legal, above that it is classified as a narcotic. The decisive factor is always the total THC, i.e., THC plus THCA multiplied by the factor 0.877. A product with 0.4% delta-9-THC and 0.9% THCA has around 1.19% total THC and is therefore a narcotic — even if the packaging says «under 1%». Anyone driving to training by car must also respect the detection limit of 1.5 µg/L THC in the blood.

All information here is not a substitute for sports medical advice; in the case of symptoms of clinical significance, medical evaluation is required.

Structure of this cluster

The subpages cover CBD in recovery, cannabis and endurance performance, the runner's high and endocannabinoids, anti-doping rules, sleep and muscle soreness, as well as the risks for licensed athletes.

Anyone competing in licensed competitions should read the anti-doping page first — it contains the only information that really matters in a worst-case scenario.

Swiss road traffic and the mobility of athletes

Many athletes use their car to travel to training or competitions. In Swiss road traffic, a strict zero-tolerance policy applies to THC, with a statutory detection limit of 1.5 micrograms of THC per litre of blood. Since legal CBD products with a total THC content of less than one percent also contain small amounts of THC, regular consumption can lead to accumulation in the body. In the worst-case scenario, this leads to the limit in the blood being exceeded, which is legally classified as an inability to drive.

The competent authorities, such as the Federal Office of Public Health (BAG) and law enforcement agencies, make no distinction here between the consumption of legal CBD and illegal cannabis. Anyone who exceeds the detection limit risks losing their driving licence and facing heavy fines. For active athletes, this means that the consumption of cannabinoid-containing products must always be calculated with regard to their own mobility and the strict Swiss traffic regulations in order to avoid legal consequences in everyday life.

• Strict zero tolerance in Swiss road traffic with a limit of 1.5 µg/L of blood.
• Risk of THC accumulation in the body, even with regular consumption of legal CBD.
• Inability to drive is legally presumed if the limit is exceeded, without a case-by-case assessment.
• Loss of driving licence and criminal consequences in the event of a positive blood test result.

Methods of administration in sport and their physiological risks

The method of consuming cannabinoids has a direct impact on the body and athletic performance. Inhalation through smoking is the most harmful method in a sports context, as combustion products strain the respiratory tract and impair oxygen transport in the blood. This reduces aerobic capacity and directly contradicts the goals of endurance sports. Although vaporising using a vaporizer is gentler on the lungs compared to smoking, it still carries long-term respiratory risks that have not yet been sufficiently researched.

Oral ingestion of oils, capsules, or infused foods bypasses respiratory strain, but comes with other disadvantages. Absorption through the gastrointestinal tract leads to a delayed and unpredictable effect, as the active ingredient must first pass through the liver. This low bioavailability makes precise dosing for recovery purposes difficult. For athletes who rely on precise routines, this unpredictability is a major disadvantage compared to established physiological recovery methods.

• Inhalation through smoking damages the lungs and permanently impairs oxygen uptake.
• Although vaporising is combustion-free, the long-term consequences for athletes are insufficiently researched.
• Oral ingestion leads to a delayed onset of action and complicates training schedule planning.
• Low bioavailability in the digestive tract requires higher and more difficult-to-calculate quantities.

Influence on the endocannabinoid system and training adaptations

The human endocannabinoid system is deeply involved in regulating homeostasis after physical exertion. Intensive training causes microtrauma and temporary inflammatory processes in the body, which serve as necessary stimuli for muscle growth and performance enhancement. The body then releases its own endocannabinoids to regulate these processes. The external intake of plant-derived cannabinoids such as CBD interferes with this sensitive biological feedback system and can alter natural processes.

Some sports science hypotheses suggest that artificially dampening inflammatory responses immediately after training could hinder the body's long-term adaptation. If the muscle's natural stress signals are suppressed too strongly by exogenous substances, the stimulus for rebuilding and supercompensation is lost. The targeted use of cannabinoids for recovery therefore requires precise timing in order not to unintentionally minimise the actual training effect.

• The endocannabinoid system regulates the body's own response to athletic training stimuli.
• Post-workout inflammation is biologically necessary for muscle building.
• External cannabinoids can weaken natural adaptation and supercompensation processes.
• The scientific data on long-term performance impairment due to CBD is still incomplete.

Quality control and risk minimization for athletes

For athletes who wish to use CBD products despite the risks, seamless quality control is essential. Since the market for hemp products is only partially standardized, the actual ingredients often deviate from the label specifications. In particular, the risk of contamination with illegal THC is high in cheap products. To avoid positive doping results or violations of the Narcotics Act, only products that have been analyzed and certified by independent Swiss laboratories should be used.

In licensed competitive sports, the rule of strict liability of the athlete applies. This means that an athlete is sanctioned even if they unknowingly consumed a contaminated CBD product. Presenting a batch-specific certificate of analysis proving the absolute absence of THC is therefore the only way to minimize the risk. Full-spectrum products should generally be avoided by ambitious athletes due to their natural residual THC content and replaced with high-purity isolates.

• Independent laboratory analyses are the only reliable source for the actual product composition.
• Strict liability in anti-doping law holds athletes fully accountable in the event of contamination.
• Full-spectrum extracts carry a systematic risk of positive THC doping tests.
• Batch-specific certificates should be actively requested from the manufacturer before purchase.

FAQ